Pembrolizumab plus Chemotherapy for Synchronous Multiple Primary Esophageal and Gingival Squamous Cell Carcinomas. Tamura H, Otsuki Y, Hosokawa A. Anticancer Res 2026;46:5759-5766.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tamura H, Otsuki Y, Hosokawa A. Pembrolizumab plus Chemotherapy for Synchronous Multiple Primary Esophageal and Gingival Squamous Cell Carcinomas. Anticancer Res 2026;46:5759-5766.
PMID: 42823147